Literature DB >> 16432752

[Chronic fistulas with impaired wound healing].

A Feser1, G Schuler, M Simon, M Lüftl.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16432752     DOI: 10.1007/s00105-005-1085-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  7 in total

1.  Steroid-responsive pyoderma gangrenosum with vulvar and pulmonary involvement.

Authors:  C Lebbé; I Moulonguet-Michau; P Perrin; F Blanc; J Frija; J Civatte
Journal:  J Am Acad Dermatol       Date:  1992-10       Impact factor: 11.527

2.  Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody).

Authors:  L Jenne; B Sauter; P Thumann; M Hertl; G Schuler
Journal:  Br J Dermatol       Date:  2004-02       Impact factor: 9.302

3.  Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management.

Authors:  D G Sheldon; L L Sawchuk; R A Kozarek; R C Thirlby
Journal:  Arch Surg       Date:  2000-05

Review 4.  Pyoderma gangrenosum: classification and management.

Authors:  F C Powell; W P Su; H O Perry
Journal:  J Am Acad Dermatol       Date:  1996-03       Impact factor: 11.527

5.  Leukocyte chemotaxis and pyoderma gangrenosum.

Authors:  P Nerella; A Daniela; M Guido; P Fabbri
Journal:  Int J Dermatol       Date:  1985 Jan-Feb       Impact factor: 2.736

6.  Pyoderma gangrenosum: a report of 44 cases with follow-up.

Authors:  P von den Driesch
Journal:  Br J Dermatol       Date:  1997-12       Impact factor: 9.302

Review 7.  Optimal treatment of pyoderma gangrenosum.

Authors:  Samuel Gettler; Marti Rothe; Caron Grin; Jane Grant-Kels
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.